Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

135
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
135
Pharmacovigilance01:19

Pharmacovigilance

764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Ethics in Research01:56

Ethics in Research

22.9K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
22.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From legalisation to practice: implementation of newly legalised health interventions in healthcare settings - a systematic review.

BMJ open·2026
Same author

Public support for mitochondrial donation: an Australian knowledge and attitudes study.

Reproductive biomedicine online·2026
Same author

Editorial: The future of agricultural biosafety regulations.

Frontiers in bioengineering and biotechnology·2025
Same author

Public funding for mitochondrial donation: An Australian public deliberation.

BMC medical ethics·2025
Same author

Reducing the regulatory burden of plant biotechnology regulations in Canada.

Genome·2025
Same author

Rate of herbicide resistant weed development: A Canadian Prairie case study.

GM crops & food·2025
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

Related Experiment Video

Updated: May 25, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.3K

Risk-appropriate, science-based innovation regulations are important.

Karinne Ludlow1, Jose Falck-Zepeda2, Stuart J Smyth3

  • 1Faculty of Law, Monash University, Clayton, Victoria, Australia.

Trends in Biotechnology
|February 27, 2025
PubMed
Summary
This summary is machine-generated.

Politicized regulations, like the Cartagena Protocol on Biosafety (CPB), hinder agricultural biotechnology innovations. Risk-appropriate rules are crucial to foster innovation and support food-insecure nations.

Keywords:
Asilomar Conferencebiosafetybiotechnologyevidencescience-based

More Related Videos

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

1.8K
Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
04:55

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

6.7K

Related Experiment Videos

Last Updated: May 25, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.3K
Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

1.8K
Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
04:55

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

6.7K

Area of Science:

  • Agricultural Science
  • Biotechnology Regulation
  • International Policy

Background:

  • Politicized and inappropriate regulations globally limit agricultural biotechnology's benefits.
  • The Cartagena Protocol on Biosafety (CPB) acts as a significant barrier to innovation, particularly for food-insecure nations.
  • International agreements promote precaution-based frameworks, eroding evidence-based regulation.

Purpose of the Study:

  • To discuss the impact of current regulatory frameworks on agricultural biotechnology innovation.
  • To highlight the importance of risk-appropriate regulation for innovation efficiency.
  • To advocate for a shift away from precaution-based regulation that stifles innovation.

Main Methods:

  • Analysis of international agreements and their impact on regulatory frameworks.
  • Review of the history of genetic modification safety assessments.
  • Discussion of the relationship between regulatory requirements and innovation rates.

Main Results:

  • Current regulations, influenced by international agreements, increasingly favor precaution over evidence.
  • Despite decades of safety data, regulatory hurdles are escalating, slowing innovation.
  • Food-insecure countries are disproportionately affected by these restrictive regulations.

Conclusions:

  • Agricultural biotechnology holds immense potential, but is hampered by inadequate and politicized regulations.
  • A move towards risk-appropriate, evidence-based regulation is essential to accelerate innovation.
  • Reforming regulatory approaches is critical for global food security and technological advancement.